全文获取类型
收费全文 | 5203篇 |
免费 | 353篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 44篇 |
儿科学 | 120篇 |
妇产科学 | 101篇 |
基础医学 | 671篇 |
口腔科学 | 58篇 |
临床医学 | 645篇 |
内科学 | 1093篇 |
皮肤病学 | 105篇 |
神经病学 | 594篇 |
特种医学 | 247篇 |
外国民族医学 | 2篇 |
外科学 | 803篇 |
综合类 | 108篇 |
一般理论 | 1篇 |
预防医学 | 286篇 |
眼科学 | 51篇 |
药学 | 407篇 |
中国医学 | 7篇 |
肿瘤学 | 260篇 |
出版年
2023年 | 25篇 |
2022年 | 40篇 |
2021年 | 134篇 |
2020年 | 90篇 |
2019年 | 119篇 |
2018年 | 145篇 |
2017年 | 114篇 |
2016年 | 139篇 |
2015年 | 135篇 |
2014年 | 181篇 |
2013年 | 278篇 |
2012年 | 344篇 |
2011年 | 342篇 |
2010年 | 226篇 |
2009年 | 186篇 |
2008年 | 257篇 |
2007年 | 297篇 |
2006年 | 232篇 |
2005年 | 245篇 |
2004年 | 224篇 |
2003年 | 205篇 |
2002年 | 189篇 |
2001年 | 88篇 |
2000年 | 81篇 |
1999年 | 77篇 |
1998年 | 94篇 |
1997年 | 69篇 |
1996年 | 65篇 |
1995年 | 43篇 |
1994年 | 52篇 |
1993年 | 54篇 |
1992年 | 43篇 |
1991年 | 39篇 |
1990年 | 54篇 |
1989年 | 74篇 |
1988年 | 56篇 |
1987年 | 66篇 |
1986年 | 46篇 |
1985年 | 42篇 |
1984年 | 42篇 |
1983年 | 24篇 |
1982年 | 22篇 |
1981年 | 16篇 |
1980年 | 17篇 |
1979年 | 26篇 |
1976年 | 13篇 |
1974年 | 20篇 |
1973年 | 19篇 |
1970年 | 16篇 |
1969年 | 13篇 |
排序方式: 共有5603条查询结果,搜索用时 15 毫秒
51.
52.
Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma 总被引:1,自引:0,他引:1
Hsu SC; Obeid OE; Collins M; Iqbal M; Chargelegue D; Steward MW 《International immunology》1998,10(10):1441-1447
Plasmid DNA vectors have been constructed with minigenes encoding a single
cytotoxic T lymphocyte (CTL) epitope from either the M2 protein of
respiratory syncytial virus (RSV) or from the nucleoprotein of measles
virus (MV) with or without a signal sequence (also called secretory or
leader sequence). Following intradermal immunization, plasmids in which the
CTL epitopes were expressed in-frame with the signal sequence were more
effective at inducing peptide- and virus- specific CTL responses than
plasmids expressing CTL epitopes without the signal sequence. This
immunization resulted in protection against MV-induced encephalitis and a
significant reduction in viral load following RSV challenge. The reduction
of viral load following RSV challenge was abrogated by prior injection with
anti-IFN-gamma antibodies. These results highlight the ability of
epitope-based DNA immunization to induce protective immune responses to
well-defined epitopes and indicate the potential of this approach for the
development of vaccines against infectious diseases.
相似文献
53.
Using a subtractlve strategy, we have cloned an activation-relatedgene from a human B cell cDNA library. Sequence analysis revealedthat this gene was identical to H12.3, a gene belonging to anexpanding family of guanlne nucleotlde-blndlng protein ßsubunlts. The expression of H12.3 was induclble in the latephase of mltogen-stlmulated T and B cells. In T cells, IL-2and IL-4 by themselves had no direct effect on the expressionof H12.3, but they could augment the level of steady-state H12.3mRNA stimulated by phytohemagglutlnln. On the other hand, IFN-and IL-6 had no obvious effect on the expression in B cellswith or without Staphytococcus aureus Cowan l-stlmulatlon. CyclosporinA, a strong immunosuppressant, Inhibited the mltogen-stlmulatedexpression of H12.3, but rapamycin, another such agent, didnot. In synchronized Jurkat cells, the expression of H12.3 hadno cell cycle-dependent decrease in S and G2/M phase, whilecyclin E, which controls the progression of the cell cycle unlate G1 phase, did show a periodic expression pattern. The resultssuggest that H12.3 might be involved in regulation of lymphocyteactivation. 相似文献
54.
Optimization of an elispot assay to detect cytomegalovirus-specific CD8+ T lymphocytes 总被引:1,自引:0,他引:1
Godard B Gazagne A Gey A Baptiste M Vingert B Pegaz-Fiornet B Strompf L Fridman WH Glotz D Tartour E 《Human immunology》2004,65(11):1307-1318
Various arguments suggest that CD8+ T lymphocytes play a major role in the control of cytomegalovirus (CMV) infection. The detection of CMV-specific CD8+ T cells may therefore provide additional information about CMV virus detection to predict the risk of development of CMV disease, especially in immunodepressed transplant recipients. We compared and tested various experimental conditions to optimize an enzyme-linked immunospot assay (Elispot) assay for the detection of CMV-specific CD8+ T lymphocytes. The indirect Elispot assay with one six-day in vitro sensitization step was found to be the most sensitive method to detect CMV-specific CD8+ T cells compared to direct Elispot with unfractionated peripheral blood mononuclear cells or purified CD8+ T cells. We showed that low doses of interleukin-2 during the in vitro culture enhanced the sensitivity of this test, and tetramer staining was performed to verify the high efficiency of this in vitro stimulation step. We directly loaded the specific CMV peptide during the Elispot assay and demonstrated that the use of T2 cells did not improve its sensitivity. Elispot for the detection of interferon-gamma appears to be more sensitive and reliable than measurement of tumor necrosis factor alpha or granzyme B. This technique was successfully applied to detect CMV-specific CD8+ T cells in human leukocyte antigen A2 (HLA-A2) and HLA-B7 healthy patients and in one lymphopenic post-transplant patient with positive CMV serology. This highly sensitive test may be a useful tool to assess T-cell immunity directed against CMV in immunodepressed patients. 相似文献
55.
Cytogenetic analysis of a mesenchymal hamartoma of the liver 总被引:4,自引:0,他引:4
F Speleman V De Telder K R De Potter P Dal Cin S Van Daele Y Benoit J G Leroy H Van den Berghe 《Cancer Genetics and Cytogenetics》1989,40(1):29-32
Cytogenetic analysis of a mesenchymal hamartoma of the liver in a 3-year-old child revealed a balanced translocation between chromosomes 15 and 19 as the sole chromosome change. 相似文献
56.
Debelenko LV; Brambilla E; Agarwal SK; Swalwell JI; Kester MB; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Chandrasekharappa SC; Crabtree JS; Kim YS; Heppner C; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Collins FS; Travis WD; Emmert-Buck MR 《Human molecular genetics》1997,6(13):2285-2290
Lung carcinoids occur sporadically and rarely in association with multiple
endocrine neoplasia type 1 (MEN1). There are no well defined genetic
abnormalities known to occur in these tumors. We studied 11 sporadic lung
carcinoids for loss of heterozygosity (LOH) at the locus of the MEN1 gene
on chromosome 11q13, and for mutations of the MEN1 gene using dideoxy
fingerprinting. Additionally, a lung carcinoid from a MEN1 patient was
studied. In four of 11 (36%) sporadic tumors, both copies of the MEN1 gene
were inactivated. All four tumors showed the presence of a MEN1 gene
mutation and loss of the other allele. Observed mutations included a 1 bp
insertion, a 1 bp deletion, a 13 bp deletion and a single nucleotide
substitution affecting a donor splice site. Each mutation predicts
truncation or potentially complete loss of menin. The remaining seven
tumors showed neither the presence of a MEN1 gene mutation nor 11q13 LOH.
The tumor from the MEN1 patient showed LOH at chromosome 11q13 and a
complex germline MEN1 gene mutation. The data implicate the MEN1 gene in
the pathogenesis of sporadic lung carcinoids, representing the first
defined genetic alteration in these tumors.
相似文献
57.
B Charpentier P Lang C Hiesse P Fixy O Lantz J Bellamy G Benoit D Fries 《Annales de médecine interne》1987,138(5):366-368
An increased incidence of Kaposi's sarcoma is well known in renal transplant recipients in whom it may represent up to 3 p. 100 of all de novo tumours. This sarcoma has a close relationship with the potential oncogenicity of the cytomegalovirus (CMV) and with chronic immunological deficiency. Anti-CMV immunity is based on the integrity of cytotoxic cellular functions such as those of cytotoxic T lymphocytes (CTL), "natural killers" cells, and K cells which function in the antibody-dependent cell cytotoxicity (ADCC) system. Two cases of Kaposi's sarcoma were observed out of a total of 700 renal transplant recipients; they underwent the following investigations: lymphocyte sub-group counts by murine monoclonal antibodies, lymphocyte proliferation to lectins and allogenic cells, NK activity and generation of specific auxiliary and cytotoxic anti-CMV cells. Both cases of Kaposi's sarcoma were seropositive for CMV and seronegative for LAV. In one case, an abnormal number of peripheral OKT9 + lymphocytes (normally a thymocytic marker) was observed with small numbers of OKT4/OKT8, a reduced proliferative response to mitogens and allogenic cells. All these in vitro changes persisted despite reduction of immunosuppressive therapy and clinical improvement. A clinical and biological cure was only obtained after withdrawal of immunosuppressive therapy and return to haemodialysis. In the second case of Kaposi's sarcoma, the initial biochemical changes were minimal and a clinical cure was obtained by decreasing the immunosuppressive therapy. These two cases illustrate the complex dysregulation of the immune system in Kaposi's sarcoma. 相似文献
58.
Paramagnetic macrocyclic chelates show promise as magnetic resonance (MR) imaging contrast agents due to stability and relaxivity comparable to those of DTPA-type chelates. For the three copper and manganese macrocyclic complexes studied in aqueous solution, T1 and T2 relaxivities ranged from 0.14 to 5.88 mM-1sec-1 at 6.25 MHz. In rats, the intravenous administration of 16 mumol/kg of Mn(cyclam) caused the liver T1 relaxation rate to double at 15 minutes after injection. T1 measurements by pulsed MR imaging and manganese analyses on excised tissue showed that both relaxation rate (1/T1) and manganese content of liver and kidney increase linearly with the dosage of Mn(cyclam). The linear relationship between 1/T1 and manganese content can be considered an "in tissue" relaxivity plot for the agent. The resulting relaxivity is 54 mM-1sec-1 in liver, compared with 3.1 mM-1sec-1 in aqueous solution. Although this work is preliminary, the implication for medical MR imaging applications is that macrocyclic contrast agents can be effective at approximately one-tenth the current typical dose used for gadolinium DTPA. 相似文献
59.
This article analyzes a series of 302 female patients prone to cystitis. The fact that these women were seen in a urological crenotherapy center highlights the very evolutive nature of the disease. The high rate of E coli present in the urine should be noted. Most of the women had a normal intravenous urogram and a normal endoscopy. The "classic" causes are rarely responsible for attacks of cystitis, but sexual intercourse and pregnancy seem to play a part. Several of the women took estroprogestative pills, or wore an intra-uterine device. The rate of bowel symptomatology-colopathy or constipation--should be noted. The article assesses the evolution of cystitis before and after crenotherapy at La Preste. 相似文献
60.
David J. Stewart Brien Benoit Michael T. Richard Herman Hugenholtz Jean Dennery Neville Russell Eric Peterson Zvonimir Grahovac Garry Belanger Jean A. Maroun Vincent Young 《Journal of neuro-oncology》1984,2(1):53-58
Summary Twenty-six adult patients with astrocytomas were treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) 180–240 mg/m2 1.V. every 6–9 weeks, with metronidazole 1.5 g/m2 p. o. 12 h and 1 h before BCNU and again 6 h and 24 h after BCNU. Of twenty-two evaluable patients, 9 (41%) responded with evidence of reduced tumor size on CT scan, 3 (14%) stabilized and 10 (45%) failed. Patients with no prior chemotherapy or radiotherapy, good performance. status, low grade tumors, and age 50 years had the highest response rates, although differences were not statistically significant. Median survival and duration of response have not been reached with a median follow-up time of ten months. Hematological toxicity was dose-limiting and was probably not augmented by the metronidazole. There was one death from infection that was possibly drug-related. Gastrointestinal toxicity was substantial, and was probably increased by the metronidazole.While the combination of BCNU and metronidazole were tolerable, the response rate seen was no higher than that noted for BCNU alone, and further studies using this dose-schedule are not recommended in astrocytomas.Presented at the 13th International Congress of Chemotherapy, Vienna Austria, August 1983. 相似文献